查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1616681

2024-2032 年聚甘油癸二酸酯 (PGS) 市場機會、成長動力、產業趨勢分析及預測

Polyglycerol Sebacate (PGS) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球聚甘油癸二酸酯(PGS) 市值為6,549 萬美元，預計2024 年至2032 年複合年成長率為10.6%。於製成的閥門和網狀物等紡織品由聚乙烯和聚酯製成。它在組織工程以及神經和心血管組織修復方面尤其有價值。除了目前在組織支架中的應用外，PGS 還可以與擠出添加劑結合使用，並用於關節置換的骨移植。雖然目前 PGS 市場仍然較小且處於發展階段，但其潛力巨大。

鑑於 PGS 能夠以更好的靈活性模仿自然組織，因此最終可能取代聚乳酸 (PLA)、聚 L-乳酸 (PLLA)、聚乙醇酸 (PGA) 和聚己內酯 (PCL) 等其他生物材料。其柔軟性、堅固性和成本效益使其成為其他可生物分解彈性體的有吸引力的替代品。 PGS 的應用包括神經引導、組織再生、血管重建和藥物傳輸系統。到2032年，軟凝膠市場預計將達到4,335萬美元，複合年成長率為9.6%。和組織支架方面。此外，糊狀 PGS 因其易於應用和定製而受到關注，使其成為再生醫學和傷口護理的理想選擇。組織工程領域在2023 年佔據45% 的市場佔有率，價值2,947 萬美元，預計到2032 年將以9% 的複合年成長率成長。組織修復的支架在再生醫學。在藥物傳輸領域，PGS 也因其受控分解特性而受到關注，從而實現更有針對性和創新的治療系統。

在北美，PGS市場預計到2032年將達到7,434萬美元，複合年成長率為12%。這一成長是由人口老化加劇以及肥胖和骨關節炎等生活方式疾病日益流行所推動的，尤其是在美國。該行業的其他參與者預計也將進入很快。此外，發展中地區（特別是東歐）的意識和需求不斷提高，將進一步推動生物材料市場的發展。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 6549 萬美元
預測值 1.4053 億美元
複合年成長率 10.6%

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
    • 主要製造商
    • 經銷商
    • 全行業利潤率
  • 產業影響力
    • 成長動力
      • 醫療產業對組織工程和再生醫學的產品需求不斷成長
      • 對生物醫學紡織品的需求不斷成長，以改善醫療產業的癒合過程
    • 市場挑戰
      • 多種產品替代品的可用性以及其性能屬性的長期資料的可用性
    • 市場機會
      • 新機遇
      • 成長潛力分析
  • 原料景觀
    • 製造趨勢
    • 技術演進
      • 永續製造
        • 綠色實踐
        • 脫碳
    • 原料的永續性
    • 價格趨勢（美元/噸），2021 - 2032
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場規模與預測：依形式，2021-2032

  • 主要趨勢
  • 軟凝膠
  • 貼上
  • 擠壓製品
  • 其他

第 6 章：市場規模與預測：按應用分類，2021-2032 年

  • 主要趨勢
  • 組織工程
  • 藥物輸送
  • 黏合劑
  • 塗料
  • 其他

第 7 章：市場規模與預測：按地區分類，2021-2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 8 章：公司簡介

  • BASF SE
  • Cambridge Polymers Group
  • Evonik Industries AG
  • Fuso Chemical Co., Ltd.
  • Orthofix International NV
  • Polymers LLC
  • PolySciTech (Akina, Inc.)
  • Resinex
  • Secant LLC
  • Sigma-Aldrich (Merck Group)
  • Synthecon Inc.
簡介目錄
Product Code: 3101

The Global Polyglycerol Sebacate (PGS) Market was valued at USD 65.49 million in 2023 and is expected to grow at 10.6% CAGR from 2024 to 2032. This versatile elastomer is widely used in bio-coating applications, particularly for textiles like valves and meshes made from polyethylene and polyester. It is especially valued in tissue engineering and nerve and cardiovascular tissue restoration. In addition to its current use in tissue scaffolding, PGS can be combined with additives for extrusion and employed in bone grafts for joint replacements. While the current market for PGS remains small and in a developmental phase, its potential is significant.

PGS could eventually replace other biomaterials like polylactic acid (PLA), poly-L-lactic acid (PLLA), poly glycolic acid (PGA), and polycaprolactone (PCL), given its ability to mimic natural tissue with better flexibility. Its softness, robustness, and cost-effectiveness make it an attractive alternative to other biodegradable elastomers. Applications of PGS include nerve guidance, tissue regeneration, blood vessel reconstruction, and drug delivery systems. The soft gel segment is expected to reach USD 43.35 million by 2032, growing at a 9.6% CAGR.PGS's flexibility and biocompatibility have made soft gels increasingly popular in medical applications, particularly in drug delivery and tissue scaffolding. Additionally, PGS in paste form is gaining attention for its easy application and customization, making it ideal for regenerative medicine and wound care. The tissue engineering segment held a 45% market share in 2023, valued at USD 29.47 million, and is projected to grow at a 9% CAGR through 2032. PGS's biocompatibility and adaptability have made it highly suitable for scaffolds that support cell growth and tissue repair in regenerative medicine. In the drug delivery space, PGS is also gaining traction due to its controlled degradation properties, enabling more targeted and innovative treatment systems.

In North America, the PGS market is expected to reach USD 74.34 million by 2032, growing at a 12% CAGR. This growth is driven by the rising aging population and the increasing prevalence of lifestyle diseases, such as obesity and osteoarthritis, particularly in the U.S. While Secant Group LLC currently leads the PGS market, other players in the biodegradable bone graft polymer industry are expected to enter soon. Moreover, increasing awareness and demand from developing regions, particularly in Eastern Europe, are set to boost the biomaterials market further.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$65.49 Million
Forecast Value$140.53 Million
CAGR10.6%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising product demand for tissue engineering and regenerative medicine in medical industry
      • 3.2.1.2 Growing demand for biomedical textiles to improve healing process in medical industry
    • 3.2.2 Market challenges
      • 3.2.2.1 Availability of several product substitutes and unavailability of long-term data on its performance attributes
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
      • 3.3.4.1 North America
      • 3.3.4.2 Europe
      • 3.3.4.3 Asia Pacific
      • 3.3.4.4 Latin America
      • 3.3.4.5 Middle East & Africa
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Form, 2021-2032 (USD Million, Tons)

  • 5.1 Key trends
  • 5.2 Soft gel
  • 5.3 Paste
  • 5.4 Extruded products
  • 5.5 Others

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

  • 6.1 Key trends
  • 6.2 Tissue engineering
  • 6.3 Drug delivery
  • 6.4 Adhesives
  • 6.5 Coatings
  • 6.6 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa

Chapter 8 Company Profiles

  • 8.1 BASF SE
  • 8.2 Cambridge Polymers Group
  • 8.3 Evonik Industries AG
  • 8.4 Fuso Chemical Co., Ltd.
  • 8.5 Orthofix International NV
  • 8.6 Polymers LLC
  • 8.7 PolySciTech (Akina, Inc.)
  • 8.8 Resinex
  • 8.9 Secant LLC
  • 8.10 Sigma-Aldrich (Merck Group)
  • 8.11 Synthecon Inc.